Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Silexion Therapeutics (SLXN) SEC Filings & 10K Form

Silexion Therapeutics logo
$7.27 -0.09 (-1.22%)
Closing price 08/15/2025 03:55 PM Eastern
Extended Trading
$7.20 -0.06 (-0.89%)
As of 08/15/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Silexion Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/12/2025
3:14 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
08/12/2025
3:16 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
08/12/2025
3:19 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
08/12/2025
9:31 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEFA14A
08/12/2025
7:31 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025
5:02 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form D
Notice of Exempt Offering of Securities 
08/01/2025
11:23 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
08/01/2025
11:23 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
08/01/2025
11:29 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2025
11:17 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2025
8:13 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEF 14A
07/29/2025
8:10 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2025
11:05 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form PRE 14A
07/16/2025
7:55 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
3:05 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025
8:15 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
3:05 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K/A
07/08/2025
8:35 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
8:29 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEFA14A
06/26/2025
3:15 PM		Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SCHEDULE 13D/A
06/23/2025
3:48 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEFA14A
06/16/2025
9:51 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEF 14A
05/29/2025
11:15 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
05/29/2025
9:14 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
3:04 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
05/23/2025
4:00 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
8:20 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
4:01 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
05/13/2025
10:36 AM		GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G/A
05/12/2025
11:12 AM		CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G/A
05/06/2025
7:35 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
05/01/2025
11:15 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
04/29/2025
3:10 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form AW
04/29/2025
3:15 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/29/2025
11:10 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
04/27/2025
11:15 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
04/23/2025
3:28 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/23/2025
8:53 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
3:06 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/10/2025
3:09 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/01/2025
11:15 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
New law could create $3.7 trillion tsunami. (Ad)

During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.

You can watch it right here.
04/01/2025
3:45 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
03/28/2025
7:30 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
3:42 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
6:27 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
03/14/2025
5:59 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
7:46 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:31 PM		GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/30/2025
8:26 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
7:56 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
11:19 AM		CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/21/2025
4:49 PM		INTRACOASTAL CAPITAL, LLC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/17/2025
5:56 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
5:44 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B4
01/15/2025
11:15 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
01/15/2025
5:02 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
4:02 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1/A
01/14/2025
5:19 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1/A
01/14/2025
5:01 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
5:00 AM		Peled Amnon (Reporting)
Silexion Therapeutics (Issuer)
Silexion Therapeutics Corp (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2024
6:08 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
5:01 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:41 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
12/10/2024
8:42 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
12/10/2024
7:48 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
5:00 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
5:05 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/29/2024
5:06 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/27/2024
5:01 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:30 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:32 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/20/2024
5:15 AM		Guangzhou Sino-Israel Bio-Industry Investment Fund LLP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SC 13D
11/14/2024
8:03 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:30 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:05 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
4:24 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/22/2024
8:02 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEF 14A
10/16/2024
11:15 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
10/16/2024
8:32 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
10/10/2024
4:00 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form PRE 14A
10/09/2024
5:04 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/01/2024
5:53 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
6:10 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:05 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:06 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
09/18/2024
3:32 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
09/17/2024
11:15 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
09/09/2024
6:33 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/09/2024
7:00 AM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:48 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/22/2024
5:44 PM		Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SC 13D
New law could create $3.7 trillion tsunami. (Ad)

During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.

You can watch it right here.
08/22/2024
4:23 PM		Moringa Sponsor, LP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SC 13D
08/21/2024
3:45 PM		Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:38 PM		Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Lushi Avner (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:43 PM		Abramov Dror Yosef (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:47 PM		Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shiloah Ilan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:48 PM		Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Hadar Ilan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:48 PM		Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Horenshtein Hadar Mirit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:49 PM		Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shirvan Mitchell (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:49 PM		Alon Ruth (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SLXN) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Generate up to $5,000/month with 10X less money?
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...
Investors Alley | Sponsored
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...
Paradigm Press | Sponsored
Trump's New Plan to “Make China Pay”
Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...
Stansberry Research | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsored